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During poliovirus infection, anterograde traffic between the endoplasmic reticulum and the Golgi is inhibited due to the action of 3A, an
87 amino acid viral protein. The ability of poliovirus protein 3A to inhibit ER-to-Golgi traffic is not required for virus growth. Instead, we
have suggested that the inhibition of host protein secretion, shown to reduce the secretion of interferon-h, IL-6, and IL-8 and the expression
of both newly synthesized MHC class I and TNF receptor in the plasma membrane of infected cells, affects growth in host organisms. To
determine whether the ability of poliovirus 3A to inhibit ER-to-Golgi traffic is conserved, the ability of 3A proteins from several
picornaviruses, including human rhinovirus 14, foot-and-mouth disease virus, enterovirus 71, hepatitis A, and Theiler’s virus, was tested.
Only the 3A proteins from another poliovirus, Sabin 3, and closely related coxsackievirus B3 inhibited ER-to-Golgi traffic as effectively as
the 3A protein from poliovirus Mahoney type 1. Site-directed mutagenesis based on these findings and the three-dimensional structure of the
amino-terminal domain of poliovirus 3A protein revealed that residues in the unstructured amino terminus of 3A are critical for the inhibition
of host protein secretion.
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Infection with poliovirus causes the inhibition of host
protein secretion by a mechanism independent of the
inhibition of other host processes such as translation and
nuclear transcription (Doedens and Kirkegaard, 1995).
Poliovirus 3A protein can, when expressed in isolation,
specifically inhibit ER-to-Golgi traffic in mammalian cells,
causing proteins otherwise destined for export to accumulate
in ER-derived membranes (Doedens et al., 1997; Neznanov
et al., 2001). The 3A-mediated inhibition of protein
secretion has been shown to reduce the secretion of antiviral
cytokines such as IL-6, IL-8, and interferon-h from polio-
virus-infected cells (Dodd et al., 2001), the concentration of
TNF receptor on the surface of infected cells (Neznanov et
al., 2001), and the presentation of antigens in the context of
MHC class I molecules (Deitz et al., 2000). However, the
consequences of these effects on viral pathogenesis are not0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: karlak@stanford.edu (K. Kirkegaard).yet known. The inhibition of host protein secretion is not
required for virus production per se, because mutant
polioviruses that do not inhibit ER-to-Golgi traffic do not
show significant growth defects in tissue culture (Bernstein
and Baltimore, 1988; Dodd et al., 2001; Doedens et al.,
1997).
Poliovirus RNA replication occurs on the cytoplasmic
surface of double-membraned vesicles that proliferate
during viral infection (Dales et al., 1965; Schlegel et al.,
1996; Suhy et al., 2000). All viral proteins required for RNA
replication, including 3A and its precursors, are physically
localized to these membranes in infected cells (reviewed in
Egger et al., 2004). Thus, 3A, its precursors, and the
complexes they form are certain to play many roles during
viral infection. Mutations in the 3A coding region give rise
to viruses defective in RNA synthesis (Giachetti et al., 1992;
Teterina et al., 2003) and cell lysis (Lama et al., 1998), but it
is not known which biochemical functions of the 3A
sequences, or of proteolytic precursors such as 3AB, are
disrupted by these mutations. Interestingly, mutations in 3A
have been correlated to dramatic changes in pathogenesis in005) 18 – 29
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and Mason, 2000; Nunez et al., 2001) and hepatitis A virus
(Beneduce et al., 1995). The ability of other picornaviruses
to inhibit host protein secretion during infection has not yet
been tested.
To understand the mechanism of action of poliovirus 3A
protein and to apply this knowledge to our understanding of
picornaviral pathogenesis, we sought to determine whether
the ability of poliovirus 3A protein to inhibit cellular protein
secretion was shared with other picornaviruses. We then
used this information, in combination with the recently
determined three-dimensional structure of the amino-
terminal domain of poliovirus 3A (Strauss et al., 2003), to
identify new loss-of-function alleles of poliovirus 3A
protein that fail to inhibit ER-to-Golgi traffic. Furthermore,
mutations could be introduced into the 3A protein of
rhinovirus 14 to confer the ability to inhibit host protein
secretion.Results
C-terminally FLAG-tagged 3A proteins do not inhibit
secretion, but can be used to monitor protein expression
Our goal was to test whether 3A proteins encoded by a
variety of picornaviruses inhibit secretion, as has been
shown for poliovirus 3A protein. To this end, various 3A
coding regions were amplified by PCR or by RT-PCR. The
resulting fragments were inserted into a dicistronic vector
with the viral 3A coding region as the first cistron and
vesicular stomatitis virus glycoprotein (VSV-G) as the
second cistron, under the translational control of the
poliovirus IRES (Fig. 1A). Expression of the 87-amino
acid 3A proteins from either poliovirus Mahoney type 1 or
Sabin type 3 could be confirmed using antibody generated
against poliovirus 3A protein encoded by the type 1 genome
(Fig. 1D; Doedens et al., 1997). However, since antibodies
to other picornaviral 3A proteins were not readily available
and, in any case, would not allow determination of the
relative abundances of disparate 3A proteins, a second set of
plasmids was made that incorporated the FLAG epitope
(DYKDDDDK) at the C terminus of each 3A protein (Fig.
1B). For the 3A proteins encoded by polioviruses 1 and 3,
addition of the FLAG epitope somewhat reduced the
amount of protein that accumulated upon transfection, as
could be determined by probing with the anti-3A antibody
(Fig. 1D; compare lanes 7 and 9 to lanes 6 and 8). However,
detection with the anti-FLAG antibody (Fig. 1E) facilitated
direct comparison with the expression of 3A proteins from
other picornaviruses; only proteins that could be detected by
immunoblotting using an anti-FLAG antibody were
included in this study.
To monitor the rate of ER-to-Golgi traffic in the presence
and absence of expressed 3A proteins, the Golgi-specific
modification of VSV-G was monitored. As can be seen inFig. 1C (lane 1, vector), when VSV-G was expressed in the
absence of any 3A protein, most of the pulse-labeled VSV-G
moved to the Golgi, becoming resistant to endoglycosidase
H cleavage, during the 30-min chase in the presence of
unlabeled amino acids. Expression of 3A protein from
poliovirus 1 caused the newly synthesized VSV-G to be
retained within the ER (Fig. 1C, lane 2), as has been shown
previously (Doedens and Kirkegaard, 1995; Doedens et al.,
1997). Expression of 3A protein from poliovirus Sabin 3,
which differs from the type 1 protein only by exchange of
Ser15 for Arg, also caused the labeled VSV-G protein to be
retained in the ER (Fig. 1C, lane 4). However, when the
FLAG-tagged version of either 3A protein was expressed,
most of the VSV-G moved to the Golgi. Thus, although
FLAG-tagged versions of each protein could accumulate in
transfected cells, they no longer inhibited ER-to-Golgi
traffic. In subsequent experiments, the ability of other
picornaviral proteins to inhibit ER-to-Golgi traffic in COS-1
cells was therefore monitored by expressing an untagged
version of each protein, and a FLAG-tagged version was
used only to monitor expression. In each case, we made the
assumption that the ability of each tagged version to
accumulate in cells either reflected or underestimated the
ability of the untagged version to accumulate, as was the
case with the poliovirus proteins.
3A protein from coxsackievirus B3 also inhibits ER-to-Golgi
traffic
We first tested whether picornaviral 3A proteins from
viruses that are closely related to poliovirus had an effect on
cellular protein secretion. When plasmids that encode 3A
proteins from poliovirus 1, coxsackievirus B3, enterovirus
71 BrCr, and hepatitis A were transfected into COS-1 cells
at 4 Ag/100-mm plate, only hepatitis A 3A could be detected
in an anti-FLAG immunoblot (Fig. 2B). It has been shown
previously that poliovirus 3A protein can inhibit ER-to-
Golgi traffic even at concentrations below the limits of
detection by immunoblot (Doedens et al., 1997), and as
expected, cells transfected with plasmids that encoded
poliovirus type 1 3A showed little Golgi-specific modifica-
tion of VSV-G protein (Fig. 2A). Similarly, coxsackievirus
3A protein expression slowed ER-to-Golgi traffic (Fig. 2A),
even though no expression of the FLAG-tagged version was
observed (Fig. 2B). No inhibition of ER-to-Golgi traffic was
observed in cells that expressed hepatitis A virus 3A protein
(Fig. 2A).
Detectable expression of FLAG-tagged 3A proteins from
enterovirus 71 and human rhinovirus (HRV) 14 could only
be achieved when the amount of transfected DNA was
increased (Fig. 2D). Under these conditions, accumulation
of FLAG-tagged 3A proteins from poliovirus 1, enterovirus
71, and rhinovirus 14 could be readily observed (Fig. 2D).
Still, only the 3A proteins from poliovirus 1 and coxsack-
ievirus B3, which remained undetectable when tagged, were
able to inhibit secretion (Fig. 2C).
Fig. 1. Effect of tagged and untagged poliovirus 3A proteins on Golgi-specific modification of VSV-G. (A) A representation of the predicted mRNA generated
by transient transfection of dicistronic plasmids used to express mutant and wild-type picornaviral 3A proteins in the first ciston, and VSV-G in the second
cistron, in COS-1 cells. The dicistronic transcript is under the transcriptional control of the SV40 promoter and the VSV-G coding region in the second cistron
is under the translational control of the internal ribosome binding site the poliovirus 5Vnon-coding region (PV 5VNCR). (B) A diagram depicting the addition of
a sequence that encodes the FLAG epitope (DYKDDDDK) at the 3Vterminus of the 3A coding region in the dicistronic plasmid shown in A. (C) VSV-G
modification in the presence of untagged and tagged poliovirus 3A proteins. COS-1 cells were transfected with dicistronic plasmids that encoded 3A proteins
from poliovirus Mahoney 1 (polio 1) or poliovirus Sabin type 3 (Sabin 3) without and with a C-terminal FLAG epitope as indicated. Twenty-four hours post-
transfection, cells were pulse-labeled for 15 min with [35S]-methionine/cysteine, chased for 30 min, harvested, and lysates were prepared. Immunoprecipitated
VSV-G was cleaved with endo H, the proteins were separated by SDS–PAGE, and the results detected using a STORM phosphorimager. (D) The relative
expression of untagged and tagged versions of the poliovirus 3A proteins was determined by immunoblot using an antibody that recognized both type 1 and
type 3 3A proteins. (E) The relative expression of FLAG-tagged proteins was determined by immunoblot using an antibody (M2) specific for the FLAG
epitope. Molecular weights (kDa) of marker proteins are indicated.
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virulent Theiler’s strain GDVII, non-virulent Theiler’s
strain BeAn, and the O/Tai strain of foot-and-mouth
disease virus (FMDV) were also monitored and tested
(Monteyne et al., 1997; O’Donnell et al., 2001; Pevear et
al., 1988). We also included the L protein of Theiler’s
virus, which is known to affect interferon secretion during
infection (Fiette et al., 1995; Lin et al., 1999; Kong and
Roos, 1991). The expression of FLAG-tagged versions of
each of these proteins was confirmed (Fig. 2F). None of
the expressed proteins, however, could be observed to alterthe rate of movement of VSV-G from the ER to the Golgi
(Fig. 2E, lanes 3–6).
Sequence comparisons of picornaviral 3A proteins
When the 3A sequences of poliovirus and coxsackievirus
B3 were compared with those of the other tested 3A proteins,
their similarities led to testable hypotheses as to the basis of
the ability to inhibit ER-to-Golgi traffic (Fig. 3). Protein 3A
is one of the least conserved picornaviral proteins; the 3A
proteins studied here, for example, vary in length from 74 to
Fig. 2. Inhibition of VSV-G modification by picornaviral proteins. (A) The effect of expressing 3A proteins from poliovirus type 1 (polio 1), coxsackievirus B3
(Cox B3), enterovirus 71 (Entero 71), and hepatitis A (Hep A) viruses on Golgi-specific modification of VSV-G after transfection of 4 Ag of plasmid DNA for
each 100 mm plate is shown. (B) The relative accumulation of FLAG-tagged versions of the various 3A proteins tested in A was determined by immunoblot.
(C) The effect of expressing several picornaviral 3A proteins, including that encoded by human rhinovirus 14 (Rhino 14) on Golgi-specific modification of
VSV-G after transfection of 4 Ag of plasmid DNA for each 100 mm plate is shown. (D) The relative accumulation of FLAG-tagged versions of the 3A proteins
tested in C was determined by immunoblot. (E) The effect of expression of 3A proteins from poliovirus type 1, Theiler’s virus BeAn (Theil B), Theiler’s virus
GDVII (Theil G), and foot-and-mouth disease virus OTai (FMDV OTai), and of the L* protein of Theiler’s GDVII (Theil L*) on Golgi-specific modification of
VSV-G, after transfection of 8 Ag of plasmid DNA for each 100 mm plate, is shown. (F) The relative accumulation of FLAG-tagged versions of the proteins
tested in E was determined by immunoblot. Molecular weights (kDa) of marker proteins are indicated.
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terminal half of the protein whose presence correlated with
the ability to inhibit ER-to-Golgi traffic was Lys9 (Fig. 3).
The structure of the first 59 amino acids of poliovirus 3A has
been determined by NMR spectroscopy (Fig. 4A; Strauss et
al., 2003). This structure reveals a dimer, whose interface is
formed between helical hairpins present in each monomer.
The amino-terminal 14 amino acids of each monomer were
found to be unstructured (Fig. 4); Lys9 lies in this region and
is thus a good candidate for one of the residues that mediates
interaction with a cellular ligand that might lend structure to
the unfolded region. The poliovirus, coxsackievirus B3, and
rhinovirus 14 sequences share a stretch of three Pro residues,
found at positions 16–18 in poliovirus 3A; given the known
propensity of proline-containing motifs to mediate protein–
protein interactions (Kay et al., 2000), these residues also
seemed to be likely candidates for involvement in theinhibition of ER-to-Golgi traffic even though they were also
present in the rhinovirus 14 sequence.
Mutagenesis of specific residues of poliovirus 3A abrogates
secretion inhibition
To facilitate testing the activity of numerous mutant 3A
proteins in transfected cells, an assay to monitor secreted
alkaline phosphatase (SEAP) in tissue-culture medium and
cells was employed. COS-1 cells were co-transfected with
plasmids that encoded SEAP and the 3A protein of interest;
thus, only secretion from transfected cells was monitored.
The plasmid-encoded alkaline phosphatase activity is known
to be resistant to heat inactivation, unlike endogenous
alkaline phosphatase activities, so the activity measured
after heat treatment represented only protein synthesized in
transfected cells. In all cases, 10 Ag/ml cycloheximide was
Fig. 3. Alignment of picornaviral 3A proteins. The sequences of many of the 3A proteins tested in Fig. 2 are shown in an alignment generated using the
TimeLogic Decypher Clustal W multiple alignment program on the website (http://www.decypher2.stanford.edu/algo-cw/cw_ax.shtml). Hydrophobic domains
thought to be involved in membrane association (Towner and Semler, 1996) have been boxed. Plus signs indicate those picornaviral 3A proteins that inhibit
Golgi-specific modification of VSV-G protein. Asterisks represent amino acids that were not shown, and the numbers indicate how many amino acids the
asterisks represent. Sequences were obtained from GenBank and from the published literature (Beneduce et al., 1995; Brown and Pallansch, 1995).
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was not synthesized during the time course; indeed, the total
amounts of SEAP remained constant throughout the experi-
ments (data not shown). The percentage of SEAP in theFig. 4. Three-dimensional structure of residues 1–58 of poliovirus type 1 3A pro
dimer of two molecules of poliovirus type 1 3A, residues 1–58 (Strauss et al., 2003
and pink). The locations of Tyr5, Lys9, Thr14, Ser15, Pro16, Pro17, Pro18, and
generated using Deep View Swiss-PDB Viewer. (B) The complete amino acid sequ
domain at the C-terminal end of the protein is shaded in green. The red asterisk den
A. Brackets indicate the regions found to be ordered in solution. The top bracket
flanks the amino acids involved in forming the helical hairpin, shaded in purple. T
correspond to the highlighted residues in A, which were changed by site-directed
the 3A-2 mutant protein.supernatant of cells co-transfected with 3A-encoding plas-
mid or treated with brefeldin A was greatly reduced
compared to cells co-transfected with control vector DNA
(Fig. 5A). In a time course of SEAP secretion from cells co-tein determined by NMR. (A) Ribbon diagram of the NMR structure of a
; PDB file 1NG7). The two monomers are shown in different colors (purple
Trp42 have been highlighted on both monomers. The ribbon diagram was
ence of poliovirus type 1 3A protein is shown. The conserved hydrophobic
otes Arg58, the most C-terminal residue in the three-dimensional structure in
denotes the entire structured domain of 3A(1–58) and the bottom bracket
he regions that are disordered in solution are underlined. The colored boxes
mutagenesis. The arrowhead points to the location of the serine insertion in
Fig. 5. Monitoring extracellularly secreted alkaline phosphatase (SEAP) as an assay of secretion from transfected cells. (A) COS-1 cells were co-transfected
with a plasmid, pGG-SEAP, that encoded heat-stable-secreted alkaline phosphatase (Gene Therapy Systems, Inc.) and either a plasmid (Fig. 1) that encoded
poliovirus type 1 3A protein or a vector control. Twenty-four hours after transfection, cells were washed, fresh medium containing either cycloheximide or
cycloheximide and 1 mg/ml brefeldin A (BFA) was added, and incubation was continued. After 90 min, both cell lysates and supernatants were heat-treated and
assayed for alkaline phosphatase activity. Maximal SEAP secretion (100%) was set at the amount of secretion in the vector control sample. The graph
represents the average and standard error from three replicate samples for each condition. (B) Time course of SEAP secretion in the presence and absence of
mutant and wild-type poliovirus 3A proteins. COS-1 cells were co-transfected with pGG-SEAP and either a vector control or a plasmid that expressed wild-
type or 3A-2 mutant poliovirus 3A protein. Cell lysates and supernatants were collected at 0, 15, 30, 45, and 60 min, heated, and assayed for plasmid-encoded
SEAP activity. Maximal SEAP secretion (100%) was set at the amount of secretion in the vector control sample at 60 min. Average values and standard error
from three replicate experiments are shown.
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3A, or DNA that expressed 3A-2 (the mutant 3A protein that
contains a Ser insertion between residues 14 and 15), the
percentage of secreted SEAP was shown to increase linearly
for 60 min. Again, 3A protein expression reduced secretion
significantly, whereas expression of the 3A-2 mutant protein
was not as effective (Fig. 5B). Therefore, the SEAP assay
yielded results consistent with previous observations, and
subsequent experiments to monitor the effects of new
mutations were either performed as time courses or at the
30-min time point, well within the linear range of the SEAP
assay.
The first mutations introduced into the 3A coding region
were T14A/S15A and P16A, substituting Ala residues for
both Thr14 and Ser15 or for Pro16, respectively. These
residues were chosen because they flank the serine insertion
site of the 3A-2 mutation (Bernstein and Baltimore, 1988;
Doedens et al., 1997), a mutation that destroys the ability of
3A protein to inhibit ER-to-Golgi traffic but has little effect
on viral viability (Dodd et al., 2001; Doedens et al., 1997).
Immunoblot analysis of the transfected cell lysates demon-
strated that wild-type and mutant 3A proteins were present at
similar abundance in transfected cells (Fig. 6A, lower panel).
Interestingly, the T14/S15A and P16A proteins retained the
ability to inhibit ER-to-Golgi traffic. Therefore, although a
single Ser insertion in this region destroyed the activity,
alanine substitutions for the neighboring residues did not.
The next region examined for residues critical to the
inhibition of secretion was the triple-proline motif at amino
acid positions 16–18: additional mutant 3A-encoding
plasmids P17A, P18A, P16A/P17A, and P16A/P17A/
P18A were shown to express 3A protein as abundantly as
the wild-type plasmid (Fig. 6B). Of these, only two mutant
3A proteins, P18A and P16A/P17A/P18A, disrupted theability of 3A protein to inhibit cellular protein secretion
(Fig. 6B). Therefore, of the three Pro residues, only Pro18 is
indispensable for protein secretion inhibition activity of 3A.
This sequence requirement for a single Pro residue could be
due to a crucial role in global folding, direct interaction with
a ligand, or a structural requirement such as demarcating the
natively unstructured N-terminal region.
Another mutation, W42F, was introduced because it is
known to eliminate viral viability (Strauss et al., 2003).
Trp42 is highly conserved among the picornaviral 3A
proteins tested here (Fig. 3) and was therefore not likely
to play a role in the inhibition of ER-to-Golgi traffic. As
expected, the W42F mutation had little effect on the ability
of 3A protein to inhibit protein secretion (Fig. 6B), again
highlighting the fact that 3A protein has multiple functions,
some of which are required for viral viability, and some of
which, such as the effect on host protein secretion, do not
correlate with growth in tissue culture but are likely to affect
pathogenesis in infected hosts.
Of the most N-terminal sequences, Lys9 is conserved
only in poliovirus and coxsackievirus 3A proteins, and Tyr5
in poliovirus, coxsackievirus, and rhinovirus 14 3A proteins
(Fig. 3). As shown in Fig. 6C, the Y5W mutation did not
disrupt the protein’s ability to inhibit cellular protein
secretion, whereas the K9G mutant 3A protein was no
longer able to inhibit secretion, displaying a defect similar to
that of 3A-2. Neither the Y5W nor the K9G mutations
interfered with 3A protein expression (Fig. 6C).
Mutations that abrogate ER-to-Golgi traffic create
loss-of-function alleles
It is often assumed that deleterious mutations simply
disrupt the normal function of the wild-type protein. We
Fig. 6. Effect of site-directed mutations on 3A-mediated inhibition of
protein secretion. (A) COS-1 cells were co-transfected with pGG-SEAP and
either vector DNA or DNA that encoded wild-type 3A protein or mutant 3A
proteins 3A-2, T14A/S15A, or P16A are shown. Samples were collected at
0, 15, and 30 min post-wash; maximal secretion (100%) was set at the
30-min time point for the vector sample; data from triplicate experiments
are shown. Below the graph, an immunoblot of an SDS gel that displayed
proteins from the 30-min time points, probed with anti-3A antibody, is
shown. (B) The effect of the indicated mutations was determined as in A.
Media and cells from the 30-min time point were collected and assayed for
heat-stable alkaline phosphatase activity; data from triplicate experiments
are shown. Below the graph, an immunoblot using anti-3A antibody is
shown. (C) The effects of mutations Y5W and K9G on SEAP secretion and
3A protein accumulation were compared to the effect of the 3A-2 mutation
as in B; data from six replicate experiments are shown.
S.S. Choe et al. / Virology 337 (2005) 18–2924would certainly like to interpret the effects of the K9G,
P18A, and 3A-2 changes as loss-of-function mutations.
However, dominant, gain-of-function alleles also existwhich, for example, form unproductive oligomeric struc-
tures or target critical components inappropriately. To test
whether several 3A alleles that do not inhibit ER-to-Golgi
traffic [poliovirus 3A-2, FLAG-tagged poliovirus 3A
(3A.FT) and FLAG-tagged enterovirus 71 3A.FT] were
recessive or dominant in combination with wild-type
poliovirus 3A with respect to inhibition of cellular protein
secretion, the amounts of co-expressed wild-type and
mutant 3A protein were varied reciprocally. As a control,
the amount of transfected wild-type 3A plasmid was
varied, while the total amount of DNA transfected was
kept constant via the addition of vector DNA (Fig. 7A).
SEAP assays revealed that cellular protein secretion was
still substantially inhibited even when wild-type 3A protein
was not detectable by immunoblot (Fig. 7A). When any of
the variant 3A-encoding plasmids was titrated into the
transfection mixtures, the effects on cellular protein
secretion were indistinguishable from the addition of
vector DNA (Figs. 7B, C, and D). In the case of 3A-2,
the expression of mutant 3A protein could be verified by
immunoblot (Fig. 7B). Therefore, we conclude that the
3A-2, 3A.FT, and enterovirus 3A.FT-encoding plasmids
are recessive, making it likely that the encoded mutant
proteins have lost the wild-type function responsible for
inhibiting ER-to-Golgi traffic.
3A protein from rhinovirus 14 can be mutagenized to inhibit
protein secretion
Lys9, present in the N-terminal region of poliovirus and
coxsackievirus 3A, was shown to be crucial to the ability of
poliovirus 3A to inhibit host protein secretion (Fig. 6C). In
the 3A sequence of rhinovirus 14, which does not inhibit
host protein secretion, the corresponding residue is Glu8;
the numbering is altered because the rhinovirus 3A
sequence also lacks Gln4 relative to the poliovirus sequence
and Pro3 relative to the coxsackievirus sequence (Fig. 3). To
test whether the ability to inhibit host protein secretion
could be conferred to rhinovirus 14 3A protein by changes
in the extreme N-terminus of the protein, the mutations E8K
and P3i (an insertion of a Pro residue at position 3) were
introduced. As shown in Fig. 8, the E8K mutation conferred
a partial ability to inhibit protein secretion to the rhinovirus
3A protein, an effect that may have been increased
somewhat by the presence of the P3i mutation as well.
Therefore, small sequence changes to the rhinovirus 14 3A
sequence can confer increased ability to inhibit host protein
secretion.Discussion
The benefit conferred to poliovirus by the ability of 3A
protein to inhibit cellular ER-to-Golgi traffic is not yet
known. It appears that the most simple possibility, that the
inhibition of protein secretion results from the role of 3A in
Fig. 7. Co-transfection of wild-type and inhibition-deficient 3A mutant proteins. (A) COS cells were co-transfected with pGG-SEAP and varying mixtures of
3A-expressing plasmid and vector as indicated. Media and cells were collected at the 30-min time point as in Fig. 6B. Maximal secretion (100%) was set as
percentage of SEAP secretion in the 30-min vector-alone sample. Below the graph, an immunoblot using anti-3A antibody is shown. (B) The ability of
decreasing amounts of wild-type 3A protein to inhibit SEAP secretion in the presence of increasing amounts of DNA encoding 3A-2 mutant protein is shown.
An immunoblot using anti-3A antibody is shown below the graph. (C) The ability of decreasing amounts of wild-type 3A protein to inhibit SEAP secretion in
the presence of increasing amounts of FLAG-tagged enterovirus 71 3A protein (Ent71 3A.FT) or (D) FLAG-tagged poliovirus 3A protein is shown. Averages
and standard error from three replicate samples are indicated.
Fig. 8. Effect of site-directed mutations on the ability of 3A from human rhinovirus 14 to inhibit protein secretion. COS-1 cells were co-transfected with pGG-
SEAP and either vector DNA, DNA that encoded wild-type 3A protein from human rhinovirus (HRV) 14, poliovirus type 1 (PV), or mutant HRV 14 and
poliovirus 3A proteins as indicated. Samples were collected at 30 min post-wash; maximal secretion (100%) was set for the vector sample; data from triplicate
experiments are shown.
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intracellular membranes, is not likely because the functions
of 3A in viral RNA replication and in inhibiting protein
secretion can be genetically separated (Table 1). As
reported previously, a mutant poliovirus, 3A-2, has been
isolated that does not display a significant growth defect in
tissue culture at 37 -C and induces the membranous
vesicles characteristic of wild-type poliovirus infection
(Bernstein and Baltimore, 1988; Dodd et al., 2001) but
fails to inhibit host protein secretion (Doedens et al., 1997;
Dodd et al., 2001). Similarly, mutations in the 3A coding
region have been identified that destroy viral viability but
not the ability of 3A protein expressed in isolation to
inhibit host protein secretion (Doedens et al., 1997; Strauss
et al., 2003; this work). It will be interesting to learn
whether the known effects of type I interferons on limiting
viral growth in a mouse model for poliovirus infection
(Ida-Hosonuma et al., 2005) will be exacerbated for mutant
viruses that allow greater amounts of type I interferon
secretion.
The ability of 3A proteins to inhibit cellular protein
secretion is not conserved among picornaviruses. In fact,
only the 3A proteins from closely related poliovirus
serotype 1, poliovirus serotype 3, and coxsackievirus B3
were found to slow ER-to-Golgi traffic in COS-1 cells
(Fig. 2). In these studies, the inhibition of ER-to-Golgi
traffic observed for poliovirus 3A protein was found to be
limited to poliovirus and coxsackievirus B3 3A proteins.
However, to conclude that the 3A proteins encoded by
rhinovirus 14, hepatitis A, foot-and-mouth disease virus,
and Theiler’s virus do not inhibit ER-to-Golgi traffic, one
must assume that each of these proteins was successfully
expressed, as suggested by the detectable expression of
their FLAG-tagged versions. Specific antibodies were not
available to confirm expression of the untagged versions,
but the expression of VSV-G protein from the second
cistron of the dicistronic mRNAs confirms in each case
that the mRNAs were transcribed and stable. We were
unable to express the untagged or tagged versions in cells
from bovine or porcine hosts. Therefore, the conclusion
that the 3A proteins from the picornaviruses tested besides
poliovirus and coxsackievirus B3 must be qualified by
these considerations.
It has been reported recently that the 3A protein from
foot-and-mouth disease virus does not inhibit proteinTable 1
Viability of viruses and ability of mutant 3A proteins to inhibit host protein
secretion for viruses that contain mutations in 3A coding region
Secretion
inhibition
Virus
viability
Reference
Wild-type + + Doedens et al., 1997
3A-2  + Doedens et al., 1997;
Bernstein and Baltimore, 1988
W42F +  This work; Strauss et al., 2003
T67I +  Doedens et al., 1997secretion in Vero cells using an immunofluorescence assay
(Moffat et al., 2005). The authors suggest that, since the
2BC protein encoded by FMDV inhibits protein secretion,
this activity of 3A protein in isolation is not needed. For
other picornaviruses, it is also possible that their different
growth strategies make inhibiting host protein secretion, and
the reduction in inflammation, immune response, and cell–
cell communication that should accompany it, less desirable.
Perhaps, for viruses such as rhinovirus, for which inflam-
mation of the infected tissues enhances viral spread, there is
even positive selection for viruses that allow inflammatory
responses.
Alignment of the 3A proteins that are capable of
inhibiting ER-to-Golgi traffic (Fig. 3) revealed one candi-
date residue, Lys9, in the amino-terminal half of the 3A
protein that correlated with this ability. Indeed, the K9G
mutation was one of the few point mutations tested that
destroyed the inhibitory activity of poliovirus 3A protein
(Fig. 6C). Other mutations that interfered with the ability of
3A to inhibit protein secretion were P18A (Fig. 6B) and
3A-2 (Doedens et al., 1997), an insertion of a Ser residue
between Thr14 and Ser15. Lys9 and Pro18 are shown in red
on the structure of the 3A(1–58) dimer in Fig. 4; we
suggest that these residues define part of the binding site of
an as-yet-unidentified ligand to which poliovirus and
coxsackievirus 3A proteins bind to effect the inhibition of
protein secretion. Consistent with the crucial role of Lys9,
altering the rhinovirus 3A protein sequence to contain a Lys
residue at the homologous position (the E8K mutation)
conferred a partial ability to block host protein secretion
(Fig. 8).
The ordering of unstructured protein domains upon
ligand binding has been found in many instances in the
protein secretory pathway (reviewed in Dafforn and Smith,
2004). One example is the formation of the SNARE
complex. The components Sec9 and Snc1, as well as the
N-and C-terminal domains of Sso1, are unstructured in
isolation, but become structured upon formation of a Sec9–
Snc-1–Sso1 ternary complex (Fiebig et al., 1999). The HIV
Nef protein is an example of a viral protein that contains
unstructured regions that are involved in regulating its
membrane-binding ability as well as its interactions with at
least 30 different binding partners (Arold and Baur, 2001).
Similarly, it is likely that the unstructured amino termini of
picornaviral 3A proteins may have different partners to
correspond to the roles of these proteins in RNA replication,
membrane rearrangements, and inhibition of the host
secretory pathway.Materials and methods
Cells
COS-1 cells were cultured as monolayers in Dulbecco’s
modified Eagle’s medium supplemented with 10% (vol/vol)
S.S. Choe et al. / Virology 337 (2005) 18–29 27calf serum, 100 units of penicillin/ml, and 100 units of
streptomycin/ml at 37 -C and 5% CO2.
Plasmids and transfections
cDNAs for rhinovirus 14 (from W. Lee, University of
Wisconsin, Madison, WI), Theiler’s virus GDVII and BeAn
(from H. Lipton, Northwestern University, IL), Hepatitis A
HM175 (from G. Morace, Instituto Superiore di Sanita,
Rome, Italy), and FMDV A12 and Otai (from P. Mason,
Plum Island Animal Disease Center, New York) were used
to amplify the 3A coding sequences by PCR. Poliovirus 3
(from Y. Maldonado, Stanford University) and enterovirus
71 BrCr (from B. Brown, CDC, Atlanta, GA) were obtained
as RNA, and the 3A regions were amplified by RT-PCR.
Oligonucleotide primers were designed to introduce a SalI
site and an AUG codon at the 5Vend and a stop codon
followed by a SmaI site at the 3Vend of each 3A protein
coding region. SalI- and SmaI-digested PCR products were
inserted into a modified version of pLink (Doedens and
Kirkegaard, 1995), pNLink (Figs. 1A–B). pNLink is the
same as pLink except that one internal SalI site was
destroyed. pNLink that lacks a coding region in the first
cistron was used as the vector control. Mutations were
introduced into the poliovirus 3A coding region by
performing site-directed mutagenesis using PCR. All clones
were sequenced to verify that the amplified regions did not
contain unintended mutations.
The pGeneGrip-Secreted Alkaline Phosphatase (pGG-
SEAP) plasmid was purchased from Gene Therapy Systems,
Inc. (San Diego, CA). It consists of the coding region for a
modified alkaline phosphatase, modified to be secreted from
the transfected cells, under the transcriptional control of a
CMV promoter. COS-1 cells were transfected in 10-cm
tissue culture dishes using Lipofectamine Plus reagents as
described by the manufacturer, with 20 Al of Plus reagent
and 30 Al of Lipofectamine reagent (Invitrogen Life
Technologies, Carlsbad, CA). pNLink-based plasmids
(8 Ag per transfection) and pGG-SEAP plasmid (2 Ag per
transfection) were used for SEAP assay transfections. Either
4 or 8 Ag of pNLink-based plasmids was used for VSV-G
modification assay transfections.
VSV-G Golgi-specific modification assay
The rate of VSV-G modification in the Golgi was
monitored essentially as described previously, where it
was shown that the inhibition of Golgi-specific modification
by wild-type poliovirus 3A protein accompanied the
retention of cargo in the endoplasmic reticulum and that a
30-min time point reflected the initial rate of Golgi-specific
modification (Doedens and Kirkegaard, 1995; Doedens et
al., 1997). Twenty-four hours post-transfection, cells in
100-mm dishes were washed with PBS and incubated for
15 min at 37 -C in DMEM lacking methionine and cysteine
(Gibco) supplemented with [35S]-methionine/cysteine(Expres35S35S label, New England Nuclear). Cells were
then washed once with DMEM that contained unlabeled
methionine and cysteine and incubated in the same medium
for 30 min at 37 -C. Cells were then washed with ice-cold
PBS, harvested, and centrifuged at 300  g for 5 min. The
supernatants were removed, and the cell pellets were lysed
by resuspending in RSB-NP40 (10 mM Tris–HCl pH 7.5,
10 mM NaCl, 1.5 mM MgCl2, 1% NP40). Nuclei and
insoluble debris were pelleted by centrifugation at 2000  g
for 10 min. Supernatants were then either stored at 80 -C
or subjected immediately to immunoprecipitation.
To immunoprecipitate VSV-G protein, 9.8 Ag mono-
clonal anti-VSV-G antibody (clone P5D4, Sigma, St. Louis,
MO) was added and the samples gently rotated at 4 -C for
2 h. Protein G agarose beads (25 Al of a 50% solution;
Gibco BRL) were added and again the samples were gently
rotated at 4 -C for 2 h, upon which the agarose beads were
collected, washed once in RSB-NP40, once in RSB-NP40
that contained an additional 500 mM NaCl, and once more
in RSB-NP40. The immune complexes were released from
the beads by adding 20 Al of a solution that contained 0.1 M
NaOAc (pH 5.5), 0.5% SDS, and 0.1 M h-mercaptoethanol,
heating to 95 -C for 5 min. Endoglycosidase H (150,000
units; New England Biolabs; Beverly MA) was added, and
samples were incubated overnight at 37 -C. Proteins were
separated by electrophoresis on a 10% SDS–PAGE gel,
dried on a gel dryer for 2 h at 80 -C, and exposure to a
phosphorimager screen. Samples were viewed on a phos-
phorimager (Molecular Dynamics, Sunnyvale, CA) and
analyzed with ImageQuant software.
SDS–PAGE gels and immunoblotting
To quantify the amount of accumulated 3A proteins,
proteins from COS-1-transfected lysates were separated by
tricine–SDS–PAGE using a 4% stacking and a 16.5%
running gel (Schagger and von Jagow, 1987), and trans-
ferred to polyvinylidene difluoride (PVDF) membranes
(Millipore, Billerica, MA) for 1 h at 800 mA using a
Hoeffer tank transfer system (Hoeffer Pharmacia Bio-
tech, San Francisco, CA). The efficiency of transfer was
verified using prestained molecular weight markers
(Amersham).
After transfer was complete, the membranes were dipped
in methanol and dried at room temperature. Membranes
were treated by incubation from 1 to 12 h at 4 -C in PBS
containing 0.1% Tween (PBS-T) and either 2% BSA or 5%
nonfat dry milk. Primary antibody was diluted in blocking
buffer or PBS-T, anti-3A at 1:10, M2 anti-FLAG (Sigma) at
1:1000, and added to the membrane for either 1 h at room
temperature or overnight at 4 -C. Next, the membranes were
washed four times in PBS-T for 10 min each time, followed
by incubation with alkaline phosphatase-conjugated don-
key-anti-mouse secondary antibody diluted 1:5000 in PBS-
T for 1 h at room temperature. Blots were developed in ECF
reagent (Amersham) for 5 min, viewed on a phosphorimager
S.S. Choe et al. / Virology 337 (2005) 18–2928(Molecular Dynamics), and analyzed with ImageQuant
software.
Alkaline phosphatase assays
From each plate of transfected cells, 0.5 ml of medium
(0.05 of the total volume) was collected and stored on ice.
Collected cells were washed once in ice-cold PBS, scraped
into 1-ml ice-cold PBS using a rubber policeman, pelleted at
500  g for 4 min at 4 -C, and lysed in 100 Al RSB-NP40
buffer containing 1 mM PMSF. Lysates were incubated on
ice for 20 min and centrifuged at 20,000  g for 20 min at
4 -C; the supernatants were collected. Supernatants and
lysates from untransfected cells were also prepared and used
as background controls. All samples were heat-inactivated
at 65 -C for 30 min and cooled to room temperature. Sam-
ples were diluted appropriately to final volumes of 20 Al and
added to a well of a flat-bottom 96-well plate along with
10 Al of 0.05% Zwittergent 3-14 (CalBiochem, EMD
Biosciences, Inc., San Diego, CA). Substrate solution was
made by dissolving para-nitrophenylphosphate (pNPP)
Sigma 104 Phosphatase Substrate (Sigma, St. Louis, MO)
to 1 mg/ml in buffer containing 1 mM MgCl2 and 100 mM
diethanolamine (pH 9.8). Substrate solution and samples
were prewarmed to 30 -C prior to mixing. Substrate solution
(200 Al) was added to each sample. After 15 min of
incubation at 30 -C, reactions were stopped by the addition
of 50 Al of 3 N NaOH. Absorbance was measured at 405 nm
on a plate reader.
Molecular modeling
Modeling was performed with the Swiss PDB Viewer
(http://www.expasy.ch/spdbv) (Guex and Peitsch, 1997).
Coordinates for 3A(1–58) were obtained from Debra
Wuttke (University of Colorado at Boulder) and can be
obtained from the NCBI library under PDB file 1NG7
(Strauss et al., 2003).Acknowledgments
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